Health+Benefits

Cigna-Express Scripts Deal Gets the Green Light

Cigna’s acquisition of Express Scripts was approved by federal officials
By Katie King Posted on September 20, 2018

Cigna’s $67 billion acquisition of pharmacy benefits manager (PBM), Express Scripts, was approved by federal officials this week.

The Council Perspective: Express Scripts is one of the last standalone PBMs. This, and other pending mergers like CVS Health and Aetna, signals a desire to lower costs and prevent any disturbance from startups and new industry players, like the recent Amazon Berkshire Hathaway JP Morgan venture. At the same time, PBMs have been criticized for their role in negotiating drug prices, leaving many questioning if mergers like this will help or hinder efforts to align incentives throughout the drug supply chain to reduce costs for end payers. To succeed, the new Cigna-Express Scripts will mostly likely need to think about its PBM arm as a value-focused component of its insurance business.

Katie King Vice President, Health Policy & Strategy, The Council Read More

More in Health+Benefits

Biased Analytics
Health+Benefits Biased Analytics
Q&A with Aaron Smith-McLallen, Director of Data Science and Healthcare Analytics...
Health+Benefits Dental Benefits’ Impact on Healthcare Costs
Good oral health could help overall well-being and mitigate rising healthcare co...
Sponsored By
Employers Are Demanding Tailored Benefits
Health+Benefits Employers Are Demanding Tailored Benefits
A specialty benefits shop can offer expertise, risk management, analysis, and ef...
Sponsored By Ryan Specialty Group
Are Alternative Health Plans the Future?
Health+Benefits Are Alternative Health Plans the Future?
A breakdown of these for-profit insurance startups that have the potential to ke...
A Pointed Conversation on Health Tech
Health+Benefits A Pointed Conversation on Health Tech
A candid discussion on healthcare point solutions, technolog...
Sponsored By Ochsner Health
Human Resources Risk Is a Business Risk
Health+Benefits Human Resources Risk Is a Business Risk
We got the new CEBE chair’s insights on five risk question...